Exact Sciences Corporation (EXAS)
NASDAQ: EXAS · Real-Time Price · USD
102.34
+0.04 (0.04%)
At close: Jan 30, 2026, 4:00 PM EST
102.21
-0.13 (-0.13%)
After-hours: Jan 30, 2026, 7:55 PM EST
Exact Sciences Employees
Exact Sciences had 7,000 employees as of December 31, 2024. The number of employees increased by 400 or 6.06% compared to the previous year.
Employees
7,000
Change (1Y)
400
Growth (1Y)
6.06%
Revenue / Employee
$440,290
Profits / Employee
-$140,940
Market Cap
19.42B
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2024 | 7,000 | 400 | 6.06% |
| Dec 31, 2023 | 6,600 | 200 | 3.13% |
| Dec 31, 2022 | 6,400 | -100 | -1.54% |
| Dec 31, 2021 | 6,500 | 1,500 | 30.00% |
| Dec 31, 2020 | 5,000 | 890 | 21.65% |
| Dec 31, 2019 | 4,110 | 2,133 | 107.89% |
| Dec 31, 2018 | 1,977 | 709 | 55.91% |
| Dec 31, 2017 | 1,268 | 532 | 72.28% |
| Dec 31, 2016 | 736 | 59 | 8.71% |
| Dec 31, 2015 | 677 | 441 | 186.86% |
| Dec 31, 2014 | 236 | 134 | 131.37% |
| Dec 31, 2013 | 102 | 15 | 17.24% |
| Dec 31, 2012 | 87 | 26 | 42.62% |
| Dec 31, 2011 | 61 | 26 | 74.29% |
| Dec 31, 2010 | 35 | 16 | 84.21% |
| Dec 31, 2009 | 19 | 15 | 375.00% |
| Dec 31, 2008 | 4 | -10 | -71.43% |
| Dec 31, 2007 | 14 | -8 | -36.36% |
| Dec 31, 2006 | 22 | -27 | -55.10% |
| Dec 31, 2005 | 49 | -22 | -30.99% |
| Dec 31, 2004 | 71 | -11 | -13.41% |
| Dec 31, 2003 | 82 | 7 | 9.33% |
| Dec 31, 2002 | 75 | 7 | 10.29% |
| Dec 31, 2001 | 68 | 24 | 54.55% |
| Dec 31, 2000 | 44 | - | - |
Sources: Annual number of employees according to filings submitted to the U.S. Securities and Exchange Commission (SEC). Data is also manually gathered from company press releases, IPO filings, and other official sources.
Related Stocks
| Company Name | Employees |
|---|---|
| Labcorp Holdings | 70,000 |
| Quest Diagnostics | 56,000 |
| ICON Public Limited Company | 41,900 |
| Mettler-Toledo International | 17,300 |
| Revvity | 11,000 |
| Illumina | 10,370 |
| Waters | 7,600 |
| Qiagen | 5,967 |
EXAS News
- 3 days ago - Alger Small Cap Focus Fund Q4 2025 Portfolio Update - Seeking Alpha
- 6 days ago - Alger Small Cap Growth Fund Q4 2025 Portfolio Update - Seeking Alpha
- 10 days ago - Alger Mid Cap Focus Fund Q4 2025 Portfolio Update - Seeking Alpha
- 4 weeks ago - Top 2 Health Care Stocks That May Crash In Q1 - Benzinga
- 4 weeks ago - Exact Sciences Shareholders Unhappy With $105 Per Share Sale to Abbott Should Contact Julie & Holleman LLP Regarding Potential Claims - GlobeNewsWire
- 7 weeks ago - Exact Sciences, the NSABP Foundation, and the German Breast Group Present Results for the Oncodetect® MRD Test in Early Triple-Negative Breast Cancer at SABCS - Business Wire
- 2 months ago - Top 2 Health Care Stocks You May Want To Dump This Month - Benzinga
- 2 months ago - Exact Sciences Reinforces International Leadership in Breast Cancer with Strong Presence at 2025 San Antonio Breast Cancer Symposium - Business Wire